These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1890350)

  • 1. [Flow cytometric DNA analysis of uterine endometrial carcinoma].
    Izumi S; Yamaoka K; Arai H; Watanabe T; Tsutsui F; Tamura S; Nozawa S; Kurihara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):722-8. PubMed ID: 1890350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.
    Lindahl B; Alm P; Killander D; Långström E; Tropé C
    Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry in invasive endometrial carcinoma. Correlations between DNA content S-phase rate and clinical parameters.
    Stendahl U; Wagenius G; Strang P; Tribukait B
    In Vivo; 1988; 2(2):123-7. PubMed ID: 2979827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
    Watanabe T; Izumi S; Yamaoka K; Tsutsui F; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
    Takahashi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
    Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in DNA content and proliferation rate between adenocarcinomas of the uterine cervix and corpus.
    Strang P; Stendahl U; Lindgren A; Sténson S
    In Vivo; 1987; 1(2):109-12. PubMed ID: 2979770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry.
    Frankfurt OS; Greco WR; Slocum HK; Arbuck SG; Gamarra M; Pavelic ZP; Rustum YM
    Cytometry; 1984 Nov; 5(6):629-35. PubMed ID: 6518938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
    Shimizu K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Flow cytometric DNA analysis of gynecologic malignant tumors using paraffin-embedded tissue].
    Tase T; Oikawa N; Toki T; Wada Y; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):87-91. PubMed ID: 3546533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA content as a prognostic factor in endometrial carcinoma.
    Newbury R; Schuerch C; Goodspeed N; Fanning J; Glidewell O; Evans M
    Obstet Gynecol; 1990 Aug; 76(2):251-7. PubMed ID: 2371030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
    Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
    Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors.
    Frankfurt OS; Slocum HK; Rustum YM; Arbuck SG; Pavelic ZP; Petrelli N; Huben RP; Pontes EJ; Greco WR
    Cytometry; 1984 Jan; 5(1):71-80. PubMed ID: 6199167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DNA content and cell cycle phase analysis in uterine sarcomas and its clinical significance].
    Tan X; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):551-4. PubMed ID: 11360642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy and S-phase fraction analyses of hyperplastic, atypical and cancerous endometrium using flow cytometry from paraffin-embedded tissues.
    Pervez S; Hitchcock A; Sinton TM; Mani A; Smith JL
    Pathol Res Pract; 2002; 198(1):13-7. PubMed ID: 11866205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
    Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
    Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of model chromosome number of cultured non-small cell lung carcinomas with DNA index of solid tumor tissue.
    Siegfried JM; Ellison DJ; Resau JH; Miura I; Testa JR
    Cancer Res; 1991 Jun; 51(12):3267-73. PubMed ID: 1645617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative prognostic significance of DNA flow cytometry and histologic grading in endometrial carcinoma.
    Quillamor RM; Furlong JW; Hoschner JA; Wynn RM
    Gynecol Obstet Invest; 1988; 26(4):332-7. PubMed ID: 3229666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.